NCT06557018View on ClinicalTrials.gov

Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

September 15, 2024

Conditions
Osteoarthritis, Knee
Interventions
DRUG

liposomal bupivacaine

liposomal bupivacaine group

DRUG

traditional peri-articular injection

traditional peri-articular injection group

Trial Locations (1)

250012

RECRUITING

Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People's Hospital), Dezhou

All Listed Sponsors
lead

Dezhou Hospital Qilu Hospital of Shandong University

OTHER